Bing

SEARCH HISTORY

At Stock Options Channel, our YieldBoost formula has looked up and down the INO options chain for the new February 2016 contracts and identified one put and one call contract of particular interest. The put contract …
The Street · 6/23/2015
Inovio Pharmaceuticals Inc. (INO) was one of the Russell 2000's biggest losers for Monday June 29 as the stock slid 6% to $7.99, a loss of $-0.51 per share. Starting at an opening price of $8.29 a share, the stock traded between $7.99 and $8.37 over the ...
Equities · 6/29/2015
Inovio Pharmaceuticals Inc
Interested in a cure for cancer? HIV? Hepatitis B? Influenza? Inovio Pharmaceuticals Inc (NASDAQ:INO) has taken that hope on step further. It’s working on vaccines for all these. And it’s getting pretty impressive results. So much so that INO will ...
Investor Place · 4/15/2015
More from Bing News
One of today's notable stocks in decline is Inovio Biomedical (AMEX:INO), down 4.9% to $8.08. The Dow Jones Industrial Average is now trading 0.8% lower to 17,802 and the S&P is trading 0.8% lower to 2,085. In the past 52 weeks, Inovio Biomedical share ...
Financial News Network Online · ByPeter Chu · 6/29/2015
When the deal was announced back in 2013, INO stock bounced up 15%, and it was certainly thought of as a major event. Therefore it is somewhat disconcerting to learn that Dr. Joseph Kim, the CEO of Inovio, stated that Roche's decision to return the …
Seeking Alpha · 1/17/2015
Looking back to 34 days ago, Inovio Pharmaceuticals Inc. (Symbol: INO) priced a 9,500,000 share secondary stock offering at $8.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go ...
NASDAQ · 6/3/2015
What: Shares of Inovio Pharmaceuticals (NASDAQ: INO ) , a clinical-stage biopharmaceutical company ... Inovio may hold plenty of potential, but it's chances of keeping up with this top stock in 2015 are possibly slim-to-none!
The Motley Fool · BySean Williams · 12/4/2014
One stock that might be an intriguing choice for investors right now is Inovio Pharmaceuticals, Inc. (INO). This is because this security in the medical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks ...
Yahoo Finance · 12/5/2014
Inovio Pharmaceuticals Inc (NASDAQ:INO) stock is down almost 10% as of 10:18 AM EST. But the stock price has recovered some losses from its intra-day low of $9.51. Inovio Pharmaceuticals announced today that it was terminating its collaboration with …
bidnessetc.com · 11/17/2014
Inovio Pharmaceuticals, Inc. (INO - Analyst Report) is a biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings ...
ZACKS · 6/10/2015